Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02864381
Recruitment Status : Completed
First Posted : August 12, 2016
Last Update Posted : October 4, 2019
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 8, 2017
Actual Study Completion Date : August 23, 2019
Certification/Extension First Submitted : November 1, 2018